Patent · US Active

Method of lyophilizing liposomes

US10028912B2 · kind B2 · utility

38Cited by

10References

18Claims

0Family size

Assignee

Celator Pharmaceuticals, Inc. · US

Inventors

Donna Cabral-Lilly · Princeton, US
Lawrence Mayer · Vancouver, CA
Paul Tardi · Surrey, CA
David WATKINS · East Greenwich, US
Yi Zeng · Chengdu, CN

Key dates

Filing date	Oct 15, 2012
Grant date	Jul 24, 2018
Priority date	—
Expiry date	Sep 29, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.